Evaluate the Pharmacokinetics of Digoxin When Coadministered With PEX168 in Healthy Adult Subjects
Status:
Completed
Trial end date:
2016-01-18
Target enrollment:
Participant gender:
Summary
To assess the effect of PEX168 doses on the pharmacokinetics of digoxin in healthy
subjects.To provide a scientific basis for clinical drug combination of PEX168.
To assess the safety of single doses of digoxin administered with and without PEX168